Cytek Biosciences, Inc. (CTKB) Accrued excise taxes for share repurchase — Quarterly & Annual

Screener

Accrued excise taxes for share repurchase at other companies

TravelzooTZOO

$33K-62.9%

ESN

Essent GroupESNT

$0-100%

ESN

Essent GroupESNT

$0-100%

CSXCSX

$12M-40.0%

AshlandASH

$250K-66.7%

Dave, Inc.DAVE

$1.71M+2,380%

Other financials

Income statement

Revenue$48.1M+5.6%

Gross profit$28.3M+18.7%

Operating income-$11.4M-7.3%

Net income-$12.2M-118%

EPS (diluted)-$0.09-125%

Balance sheet

Cash & equivalents$73.8M-2.2%

Total debt$17.0M-6.6%

Total equity$322.0M-14.7%

Total assets$446.9M-9.4%

Cash flow

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+40.5%

Free cash flow-$849.0K+42.2%

Valuation

Market cap$540.73M+9.7%

Enterprise value$483.92M+11.1%

P/S2.6×+0.1×

Profitability

Gross margin53.2%-1.2pp

Operating margin-21.6%—

Net margin-39%—

FCF margin-5.8%-11.4pp

Returns & leverage

Return on equity-23%—

Debt / equity0.1×0.0×

Current ratio4.5×-0.7×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept ctkb:AccruedExerciseTaxesForShareRepurchase.

The source filing: Cytek Biosciences, Inc.’s 10-K, filed February 26, 2026. Open the filing →

Filed: Feb 26, 2026, 4:37 PM EST
Fiscal year: FY2025
Accession: 0001628280-26-012352

FAQ

What is Cytek Biosciences, Inc.'s accrued excise taxes for share repurchase?: Cytek Biosciences, Inc. (CTKB) reported accrued excise taxes for share repurchase of $0 in Q4 2025.
What does accrued excise taxes for share repurchase mean?: Accrued excise taxes for share repurchase as reported by Cytek Biosciences, Inc. Common Stock.

Ask your AI about Cytek Biosciences, Inc.'s accrued excise taxes for share repurchase.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk